A Study of the Effectiveness And Safety Of Lidoderm® As Add-On Treatment in Patients With Postherpetic Neuralgia, Diabetic Neuropathy, or Low Back Pain

Clinical trial NCT00904020 · COMPLETED

Trial details

NCT number: NCT00904020
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Postherpetic Neuralgia Diabetic Neuropathy Low Back Pain

Start date: 2002-06-01
Primary completion: 2002-11-01
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.